Initiates Coverage on Electromed (NYSE:ELMD) started coverage on shares of Electromed (NYSE:ELMDGet Rating) in a research report issued to clients and investors on Tuesday. The brokerage set a “strong-buy” rating on the stock.

NYSE:ELMD opened at $12.65 on Tuesday. Electromed has a one year low of $8.98 and a one year high of $13.85. The company has a market cap of $107.94 million, a price-to-earnings ratio of 57.50, a P/E/G ratio of 4.90 and a beta of 0.62. The firm has a 50-day simple moving average of $12.41.

About Electromed (Get Rating)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

See Also

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with's FREE daily email newsletter.